The management team of Cognos Therapeutics Inc. (Cognos) is committed to excellence in leadership and strategic innovation in its pursuit of the vision and goals established by the Cognos Board of Directors. The executive team is comprised of seasoned and forward thinking individuals who have each achieved success in their areas of expertise with previous companies. Not only is their leadership well recognized, but more importantly is their ability to inspire and direct the teams and individuals who are working to bring Cognos’ unique product technology to commercial viability.
Chief Executive Officer
Chief Innovation Officer
Thomas Chen, MD, PhD
Chief Neuro-Surgeon and Oncology Officer
Winston Wu, PhD
Senior Vice President of Product Development and Chief Technology Officer
VP Software Engineering
Mr. Abram is responsible for fixed and mobile application development, cloud infrastructure, and data analytics solutions and AIs for the company.
Dr. SUSAN ALPERT, MD, PhD
Lead Regulatory Consultant
Dr. Alpert brings over three decades of experience in helping organizations like the FDA, Medtronic and Accelmed in setting and achieving the standards of compliance for regulatory acceptance of advanced medical technologies.
Thomas Lobl, PhD
Chief Operating Officer
As Chief Operating Officer for Cognos, Dr. Lobl brings over four decades of experience in the successful development and growth of medical technology companies. He is responsible for the strategic management of Cognos’ resources as well as the implementation of effective processes and team alignment in the operation of the company.